Setolide tablets, a treatment for peptic ulcers, were released on July 25th.

Setoride tablets increase the synthesis of prostaglandin and promote mucus secretion, a defense factor for the gastric mucosa. In addition, it exhibits anti-inflammatory effects, gastric mucosal regeneration, and defense factor enhancement through antioxidant effects.

In addition, in the treatment of alcoholic gastritis, it has the advantage of faster duration of effect and faster onset of effect compared to other drugs.

With the launch of Setorid tablets, it is expected that KyungDong Pharm Co., Ltd.'s overall peptic ulcer medication product line will grow along with the existing Rebamide tablets (Rebamipide 100㎎).

Product Name

Setorid Jeong

Ingredient content

1 tablet contains 95% ethanol soft extract of leaf extract (20 → 1) 60
(0.48 to 1.44 mg as eupatillin, 0.15 to 0.45 mg as zoseocidin)

Appearance

Green oval film-coated tablets

Indications

Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) of the following diseases:
Prevention of acute gastritis, chronic gastritis, and gastritis caused by NSAIDs administration

Dosage and usage

1 tablet at a time, oral administration 3 times a day

How to save

Airtight container, stored at room temperature (1~30℃)

Packaging unit

30 tablets, 300 tablets

Insurance claim code

 648103570


※ Please refer to the product manual for other details such as precautions for use.